← Open Payments lookup

NICHOLAS SLUSS: Open Payments

NPI 1093924201 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,157 in 71 payments from 19 companies in 2025. Trend: 2023 $1,430 · 2024 $2,252 · 2025 $1,157

Food & beverage: $1,157
CompanyPaymentsAmount
Novo Nordisk Inc19$264
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$203
ABBVIE INC.16$183
GlaxoSmithKline, LLC.6$92
AstraZeneca Pharmaceuticals LP3$53
Bayer Healthcare Pharmaceuticals Inc.2$44
Amgen Inc.2$36
Dexcom, Inc.1$35
PFIZER INC.2$34
Abbott Laboratories2$33

Products named: CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, Ozempic, Rybelsus, Wegovy, AIRSUPRA, QULIPTA.

Industry payments across VA — which companies pay providers there.